Figure 1.
Screening of tsRNAs in patients with Colorectal Cancer (CRC). (A) Relative expression levels of two lowly expressed tsRNAs in 20 pairs of CRC tissues. (B) Expression levels of tRF5-23-GlyTCC-2 in 32 pairs of CRC tissues and their corresponding paracancerous tissues. (C) Correlation analysis of tRF5-23-GlyTCC-2 expression levels between 32 CRC tissues and their corresponding serum samples. (D) Expression levels of tRF5-23-GlyTCC-2 in serum samples from CRC patients (n=32) and healthy donors (n=32). (E) Expression levels of tRF5-23-GlyTCC-2 across different CRC cell lines.
